Stoke Therapeutics (NASDAQ:STOK) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Stoke Therapeutics (STOK) operate in?

Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Stoke Therapeutics Stock (NASDAQ: STOK) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 541.88K
Day Range	- - -
52 Wk Range	3.77 - 17.58
Market Cap	$596.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	18.89%
Days to Cover	22.33

Recent News

Enerpac Tool Group, Singular Genomics Systems And 3 Stocks To Watch On Monday

Avi Kapoor

What's Going On With Stoke Therapeutics Stock Tuesday?

After the market close on Tuesday, Stoke Therapeutics announced a proposed underwritten public offering of up to $75 million of its common stock. The company also intends to grant the underwriters a 30-day window to purchase up to an additional 15% of the shares in the public offering.

Adam Eckert

Crude Oil Moves Lower; TD SYNNEX Earnings Top Estimates

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 80 points on Tuesday. The Dow traded up 0.21% to 39,397.20 while the NASDAQ rose 0.23% to 16,421.62. The S&P 500 also rose, gaining, 0.17% to 5,227.03.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 541.88K
Day Range	- - -
52 Wk Range	3.77 - 17.58
Market Cap	$596.94M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	18.89%
Days to Cover	22.33

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Stoke Therapeutics (STOK) stock?

You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.

View our list of the best stock brokerages

Who are Stoke Therapeutics (STOK) competitors?

Other companies in Stoke Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT) and Replimune Group (NASDAQ:REPL).

What is the forecast, or price target, for Stoke Therapeutics (STOK) stock?

Stoke Therapeutics has a consensus price target of $24.00.

What is the current price for Stoke Therapeutics (STOK)?

The stock price for Stoke Therapeutics (NASDAQ: STOK) is $11.27 last updated November 21, 2024 at 4:00 PM EST.

Does Stoke Therapeutics (STOK) pay a dividend?

There are no upcoming dividends for Stoke Therapeutics.

When is Stoke Therapeutics (NASDAQ:STOK) reporting earnings?

Stoke Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is Stoke Therapeutics (STOK) going to split?

There is no upcoming split for Stoke Therapeutics.

What sector and industry does Stoke Therapeutics (STOK) operate in?

Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Stoke Therapeutics

Stoke Therapeutics (STOK) Forecast